Lymphogranulomatosis X: complete remission by low dose interferon-alpha.
Meuthen
I
I
Städtisches Krankenhaus Holweide, Köln.
Lennert
K
K
Siegert
W
W
D001796:Blood Protein Disorders / Q000628:therapy*; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000628:therapy*; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012074:Remission Induction; D013997:Time Factors
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins